24 May 2013
Keywords: exelixis, deal, b-ms, worth, over, 240m, drug
Article | 22 December 2008
Drug major Bristol-Myers Squibb has entered a global collaboration with fellow USA-based Exelixis worth at least $240.0 million to the latter
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2008
© 2013 thepharmaletter.com